PATENT CLAIM ANALYSIS

Application Number: 16184498
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "093400"]

Abstract:
Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.

Claim (Index 8):
The pharmaceutical composition of  claim 1 , wherein the at least one species of gram negative bacteria comprises  Acinetobacter radioresistens, Moraxella osloensis, Pantoea septica, Pseudomonas luteola, Pseudomonas aeruginosa, Pseudomonas oryzibhabitns,  or  Methylobacterium  spp.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 98.0
- Lexical Diversity: 1.32353
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15939066', '16042939', '16014971', '14350598', '15534979']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6925973928836175
- 35 USC 102 Novelty (BERT): 0.5189172105579771
- Combined Prediction Score: 0.6752293746510536
- Mean Citation Score: 245.39435000000003
- Max Citation Score: 309.52994
- Similarity Product: 268.4632237053824

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test